Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
215.4 SEK | -0.19% | -8.81% | -19.57% |
Mar. 22 | Nordic Stocks Declined Friday; BioArctic Series B Took Biggest Hit | DJ |
Mar. 22 | BioArctic Flags Delay in EU Health Regulator's Evaluation of Azlheimer’s Disease Drug | MT |
Sales 2023 | 616M 57.52M | Sales 2024 * | 502M 46.92M | Capitalization | 19.02B 1.78B |
---|---|---|---|---|---|
Net income 2023 | 229M 21.38M | Net income 2024 * | 16M 1.49M | EV / Sales 2023 | 37.4 x |
Net cash position 2023 | 607M 56.65M | Net cash position 2024 * | 838M 78.22M | EV / Sales 2024 * | 36.2 x |
P/E ratio 2023 |
103
x | P/E ratio 2024 * |
1,083
x | Employees | 88 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 44.12% |
Latest transcript on BioArctic AB
1 day | -0.19% | ||
1 week | -8.81% | ||
Current month | +0.47% | ||
1 month | -2.97% | ||
3 months | -21.96% | ||
6 months | -23.07% | ||
Current year | -19.57% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 14-01-26 | |
Founder | 77 | 03-01-23 | |
Founder | 75 | 03-01-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eugen Steiner
CHM | Chairman | 70 | 16-12-31 |
Director/Board Member | 58 | 23-05-31 | |
Director/Board Member | 56 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.25% | 5 M€ | +12.89% | ||
0.89% | 17 M€ | -0.46% | ||
0.25% | 159 M€ | +9.30% | - | |
0.19% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 215.4 | -0.19% | 35,675 |
24-03-27 | 215.8 | -1.55% | 69,201 |
24-03-26 | 219.2 | +1.95% | 101,712 |
24-03-25 | 215 | +0.66% | 132,773 |
24-03-22 | 213.6 | -9.57% | 430,956 |
Delayed Quote Nasdaq Stockholm, March 28, 2024 at 07:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.57% | 1.78B | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |